LBA62 Preoperative modified FOLFIRINOX (mFOLFIRINOX) with or without chemoradiation (CRT) in borderline resectable pancreatic cancer (BRPC): Results from the randomized phase II trial PANDAS/PRODIGE 44

FOLFIRINOX
DOI: 10.1016/j.annonc.2024.08.2304 Publication Date: 2024-09-17T21:05:24Z